Skull base tumors constitute one of the established indications for particle therapy, specifically proton therapy. However, a number of prognostic factors, practical clinical management issues, and the emerging role of carbon ion therapy remain subjects of active clinical investigation. This review summarizes these topics, assesses the present status, and reflects on future research directions focusing on the management of chordomas, one of the most aggressive skull base tumors. In addition, the role of particle therapy for benign tumors of the skull base, including pituitary adenoma and acoustic neuroma, is reviewed
Proton therapy is characterized by certain physical properties leading to a reduction in integral do...
Background: Skull base chordomas are rare and heterogeneously behaving tumors. Though still classifi...
Abstract: Purpose. Our purpose was to discuss the optimal treatment and outcomes for patients with s...
Chordoma is a rare, slow-growing, locally aggressive, primary bone tumor that arises from the skull ...
Chordoma is a rare, slow-growing, locally aggressive, primary bone tumor that arises from the skull ...
BACKGROUND: Chordomas are rare tumours affecting the skull base. There is currently no clear consens...
Chondrosarcoma (CSA) of the skull base (SB) is an uncommon, slowly growing, neoplasm comprising appr...
Background: Chordoma located in the skull base is usually a challenging surgical condition. It is of...
An extremely large variety of benign and malignant tumours occur at skull base; these tumour lesions...
Background: Chordoma located in the skull base is usually a challenging surgical condition. It is of...
Aim: This study presents an analysis (efficacy and toxicity) of outcomes in patients with skull-base...
BACKGROUND: Head and neck tumors are often located near critical organs, making it impossible to d...
ADVANCES IN KNOWLEDGE This review details the indication of brain tumors for proton therapy and g...
The aim of this study is to evaluate results in terms of local control (LC), overall survival (OS) a...
Purpose: To evaluate the effectiveness of external-beam proton therapy (PT) on local control and sur...
Proton therapy is characterized by certain physical properties leading to a reduction in integral do...
Background: Skull base chordomas are rare and heterogeneously behaving tumors. Though still classifi...
Abstract: Purpose. Our purpose was to discuss the optimal treatment and outcomes for patients with s...
Chordoma is a rare, slow-growing, locally aggressive, primary bone tumor that arises from the skull ...
Chordoma is a rare, slow-growing, locally aggressive, primary bone tumor that arises from the skull ...
BACKGROUND: Chordomas are rare tumours affecting the skull base. There is currently no clear consens...
Chondrosarcoma (CSA) of the skull base (SB) is an uncommon, slowly growing, neoplasm comprising appr...
Background: Chordoma located in the skull base is usually a challenging surgical condition. It is of...
An extremely large variety of benign and malignant tumours occur at skull base; these tumour lesions...
Background: Chordoma located in the skull base is usually a challenging surgical condition. It is of...
Aim: This study presents an analysis (efficacy and toxicity) of outcomes in patients with skull-base...
BACKGROUND: Head and neck tumors are often located near critical organs, making it impossible to d...
ADVANCES IN KNOWLEDGE This review details the indication of brain tumors for proton therapy and g...
The aim of this study is to evaluate results in terms of local control (LC), overall survival (OS) a...
Purpose: To evaluate the effectiveness of external-beam proton therapy (PT) on local control and sur...
Proton therapy is characterized by certain physical properties leading to a reduction in integral do...
Background: Skull base chordomas are rare and heterogeneously behaving tumors. Though still classifi...
Abstract: Purpose. Our purpose was to discuss the optimal treatment and outcomes for patients with s...